Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae: nested cohort within a multicenter clinical trial-Reference-Cited by-同舟云学术

Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae: nested cohort within a multicenter clinical trial

Published:2013 Issue:3 Volume:19 Page:472-479
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Fujita Jiro,Cash Haley L.,Niki Yoshihito,Kadota Jun-ichi,Yanagihara Katsunori,Kohno Shigeru,Kaku Mitsuo,Watanabe Akira,Aoki Nobuki,Hori Seiji,Tanigawara Yusuke

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s10156-012-0514-4

Reference23 articles.

1. Resistance among Streptococcus pneumoniae: implications for drug selection;Appelbaum;Clin Infect Dis,2002

2. Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia;File;Clin Microbiol Infect,2006

3. Sitafloxacin: in bacterial infections;Keating;Drugs,2011

4. Clinical evaluation methods for new antimicrobial agents to treat respiratory infections: report of the Committee for the Respiratory System, Japan Society of Chemotherapy;Saito;J Infect Chemother,1999

5. National Committee for Clinical Laboratory Standards (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Sixth edition. NCCLS document M7-A6. NCCLS, Wayne, PA

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?;Pharmaceutics;2023-03-01

2. Efficacy and Safety of Sitafloxacin in the Treatment of Acute Bacterial Infection: A Meta-analysis of Randomized Controlled Trials;Antibiotics;2020-03-02

3. The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial;Journal of Infection and Chemotherapy;2019-11

4. Correlations between extent of X-ray infiltration and levels of serum C-reactive protein in adult non-severe community-acquired pneumonia;Journal of Infection and Chemotherapy;2015-06

5. Antibiotics for community-acquired pneumonia in adult outpatients;Cochrane Database of Systematic Reviews;2014-10-09